A Study to Evaluate Safety and Therapeutic Activity of RO6874281 in Combination with Pembrolizumab, in Participants with Advanced or Metastatic Melanoma
Clinical trial NCT03875079 · COMPLETED
Trial details
- NCT number
- NCT03875079
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2022-07-14
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.